A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human

Physiological Genomics - Tập 29 Số 2 - Trang 99-108 - 2007
Reza M. Salek1, Mahon L. Maguire2, Elizabeth Bentley3, Denis V. Rubtsov2, Tertius Hough4, Michael Cheeseman4, David Brandariz-Núñez5, Brian C. Sweatman5, John N. Haselden5, Roger Cox3, S. C. Connor5, Julian L. Griffin2
1Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom
2Department of Biochemistry, University of Cambridge, Cambridge
3Mammalian Genetics Unit, Medical Research Council (MRC) Harwell, Oxfordshire
4The Mary Lyon Centre, MRC Harwell, Harwell, Oxfordshire
5Safety Assessment, GlaxoSmithKline, Ware, Herts, United Kingdom

Tóm tắt

Type 2 diabetes mellitus is the result of a combination of impaired insulin secretion with reduced insulin sensitivity of target tissues. There are an estimated 150 million affected individuals worldwide, of whom a large proportion remains undiagnosed because of a lack of specific symptoms early in this disorder and inadequate diagnostics. In this study, NMR-based metabolomic analysis in conjunction with multivariate statistics was applied to examine the urinary metabolic changes in two rodent models of type 2 diabetes mellitus as well as unmedicated human sufferers. The db/db mouse and obese Zucker ( fa/fa) rat have autosomal recessive defects in the leptin receptor gene, causing type 2 diabetes. 1H-NMR spectra of urine were used in conjunction with uni- and multivariate statistics to identify disease-related metabolic changes in these two animal models and human sufferers. This study demonstrates metabolic similarities between the three species examined, including metabolic responses associated with general systemic stress, changes in the TCA cycle, and perturbations in nucleotide metabolism and in methylamine metabolism. All three species demonstrated profound changes in nucleotide metabolism, including that of N-methylnicotinamide and N-methyl-2-pyridone-5-carboxamide, which may provide unique biomarkers for following type 2 diabetes mellitus progression.

Từ khóa


Tài liệu tham khảo

10.1007/s11892-004-0053-1

10.1016/0304-4165(65)90048-6

10.1152/ajprenal.00396.2003

10.1021/tx9700679

10.1152/ajprenal.1977.233.5.F373

Buckingham RE, Al-Barazanji KA, Toseland CD, Slaughter M, Connor SC, West A, Bond B, Turner NC, Clapham JC. Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes 47: 1326–1334, 1998.

10.1007/BF00253406

10.1002/art.21331

10.3181/00379727-173-41611

10.1080/13547500400006005

10.1111/j.2042-7158.1997.tb06808.x

10.1080/13547500410001720767

10.1016/0010-4809(84)90002-8

Eriksson I, Johansson E, Kettaneh-Wold N, Wold S. Multi- and Megavariate Data Analysis. Principles and Applications. Umea, Sweden: Umetrics Acedemy, 2001.

10.1016/0079-6565(95)01017-3

Frayn K. Metabolic Regulation: A Human Perspective. Oxford, UK: Blackwell Science, 2003.

10.1007/BF01868535

10.1016/S0014-5793(00)02147-5

10.1007/BF00585975

10.1098/rstb.2003.1411

Gullans SR, Heilig CW, Stromski ME, Blumenfeld JD. Methylamines and polyols in kidney, urinary bladder, urine, liver, brain, and plasma. An analysis using 1H nuclear magnetic resonance spectroscopy. Renal Physiol Biochem 12: 191–201, 1989.

10.1111/j.1748-1716.2006.01573.x

10.1007/s00125-006-0271-y

10.1002/(SICI)1099-1492(199806/08)11:4/5<235::AID-NBM507>3.0.CO;2-V

10.1007/s00335-002-2188-1

Ismail AA, Gill GV. The epidemiology of Type 2 diabetes and its current measurement. Baillieres Best Pract Res Clin Endocrinol Metab 13: 197–220, 1999.

10.2337/diab.43.5.629

10.1016/0014-4800(80)90030-1

10.1097/01.hjh.0000188415.65040.5d

10.1016/S0066-4103(08)60035-6

10.7326/0003-4819-130-8-199904200-00014

10.1067/mlc.2001.115717

10.1002/dmr.5610070106

10.1016/0002-9343(88)90402-0

10.1046/j.1463-1326.1999.00014.x

10.1080/1354750031000149124

10.1007/BF00218127

10.1023/B:MCBI.0000049359.66669.29

10.1021/pr060265y

10.1507/endocrj.44.671

10.1042/cs0930565

10.1007/BF01345289

10.3181/00379727-214-44090

Wolf H. The effect of hormones and vitamin B6 on urinary excretion of metabolites of the kynurenine pathway. Scand J Clin Lab Invest 136: 1–186, 1974.

10.1016/0009-8981(90)90160-T

10.1038/414782a

10.1210/endo-90-5-1320